Clinical Trials Logo

Clinical Trial Summary

Assessment of efficacy and tolerance of a new anti-dizziness drug in acute vertigo.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01583738
Study type Interventional
Source Pierre Fabre Medicament
Contact
Status Completed
Phase Phase 2
Start date April 2012
Completion date April 2013